Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRX-2 Regimen in Resectable Head and Neck Cancer
NCT00210470Phase 2Completed
- Sponsor
- Brooklyn ImmunoTherapeutics, Inc.
- Start
- Jul 2005
- Primary completion
- Dec 2010
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of citoplurikin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Brooklyn ImmunoTherapeutics, Inc.. Started Jul 2005; status: completed.
02
Drugs
citoplurikin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00210470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210470.